Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022582503> ?p ?o ?g. }
- W2022582503 endingPage "440" @default.
- W2022582503 startingPage "430" @default.
- W2022582503 abstract "The lipidosterolic extract of Serenoa repens (Permixon™) is commonly used to treat lower urinary tract symptoms related to benign prostatic enlargement. Pertinent peer-reviewed literature was critically analysed with the aim of clarifying the role of Permixon™ in view of recent basic science and clinical data. MEDLINE and Cochrane Library searches were used to assess articles published between 1995 and 2005. The key words “Serenoa repens,” “Saw palmetto,” “Permixon™,” “benign prostatic hyperplasia,” “lower urinary tract symptoms,” “chronic prostatitis,” and “prostate cancer” were used. The chemical structure of Permixon™, its efficacy and tolerability, and the comparative studies between Permixon™ and inhibitors of both 5-α-reductase and α-blockers were considered and discussed. The basic rationale behind the therapeutic effects of Permixon™ is sound. Efficacy and safety of the drug are clearly shown. Comparative studies showed similar results between Permixon™, α-blockers, and finasteride in terms of efficacy. Also the tolerability profile of Permixon™ has been shown to be excellent. Although some methodologic limitations hampered the positive results shown in the early studies on Serenoa repens in the treatment of lower urinary tract symptoms due to benign prostatic enlargement, recent sound research clearly revealed the positive role of Permixon™." @default.
- W2022582503 created "2016-06-24" @default.
- W2022582503 creator A5003714015 @default.
- W2022582503 creator A5031111261 @default.
- W2022582503 creator A5031550729 @default.
- W2022582503 creator A5039363062 @default.
- W2022582503 creator A5051984796 @default.
- W2022582503 creator A5061623935 @default.
- W2022582503 creator A5088744931 @default.
- W2022582503 date "2006-04-01" @default.
- W2022582503 modified "2023-10-18" @default.
- W2022582503 title "A Critical Analysis of Permixon™ in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement" @default.
- W2022582503 cites W1530925956 @default.
- W2022582503 cites W1548598583 @default.
- W2022582503 cites W1712693945 @default.
- W2022582503 cites W1966236678 @default.
- W2022582503 cites W1967521723 @default.
- W2022582503 cites W1968865985 @default.
- W2022582503 cites W1971807271 @default.
- W2022582503 cites W1974392957 @default.
- W2022582503 cites W1976273250 @default.
- W2022582503 cites W1977648249 @default.
- W2022582503 cites W1983702648 @default.
- W2022582503 cites W1986033833 @default.
- W2022582503 cites W1991325884 @default.
- W2022582503 cites W1994049856 @default.
- W2022582503 cites W1995809310 @default.
- W2022582503 cites W1999515078 @default.
- W2022582503 cites W2000012205 @default.
- W2022582503 cites W2002037918 @default.
- W2022582503 cites W2002658357 @default.
- W2022582503 cites W2010314100 @default.
- W2022582503 cites W2011747538 @default.
- W2022582503 cites W2016481427 @default.
- W2022582503 cites W2021378298 @default.
- W2022582503 cites W2021648001 @default.
- W2022582503 cites W2022065845 @default.
- W2022582503 cites W2026798051 @default.
- W2022582503 cites W2034333489 @default.
- W2022582503 cites W2036455089 @default.
- W2022582503 cites W2038162032 @default.
- W2022582503 cites W2038274926 @default.
- W2022582503 cites W2038608100 @default.
- W2022582503 cites W2042366482 @default.
- W2022582503 cites W2043039461 @default.
- W2022582503 cites W2043931581 @default.
- W2022582503 cites W2044350781 @default.
- W2022582503 cites W2046890382 @default.
- W2022582503 cites W2047589511 @default.
- W2022582503 cites W2053298562 @default.
- W2022582503 cites W2055660563 @default.
- W2022582503 cites W2057809575 @default.
- W2022582503 cites W2058247236 @default.
- W2022582503 cites W2063481167 @default.
- W2022582503 cites W2065016066 @default.
- W2022582503 cites W2067102078 @default.
- W2022582503 cites W2067598635 @default.
- W2022582503 cites W2068577816 @default.
- W2022582503 cites W2074930094 @default.
- W2022582503 cites W2076133875 @default.
- W2022582503 cites W2081004763 @default.
- W2022582503 cites W2081251422 @default.
- W2022582503 cites W2088371750 @default.
- W2022582503 cites W2089291054 @default.
- W2022582503 cites W2089892832 @default.
- W2022582503 cites W2090844907 @default.
- W2022582503 cites W2091841967 @default.
- W2022582503 cites W2092844578 @default.
- W2022582503 cites W2093024436 @default.
- W2022582503 cites W2096424916 @default.
- W2022582503 cites W2105900553 @default.
- W2022582503 cites W2106183208 @default.
- W2022582503 cites W2112474864 @default.
- W2022582503 cites W2113745250 @default.
- W2022582503 cites W2140416237 @default.
- W2022582503 cites W2143052023 @default.
- W2022582503 cites W2146268113 @default.
- W2022582503 cites W2147390626 @default.
- W2022582503 cites W2150687192 @default.
- W2022582503 cites W2157073178 @default.
- W2022582503 cites W2157387036 @default.
- W2022582503 cites W2162996662 @default.
- W2022582503 cites W2164915340 @default.
- W2022582503 cites W2165530215 @default.
- W2022582503 cites W2331302678 @default.
- W2022582503 cites W2334427329 @default.
- W2022582503 cites W2337196267 @default.
- W2022582503 cites W2395601383 @default.
- W2022582503 cites W2413002190 @default.
- W2022582503 cites W2413966905 @default.
- W2022582503 cites W2417785182 @default.
- W2022582503 cites W2470299285 @default.
- W2022582503 cites W3141076278 @default.
- W2022582503 doi "https://doi.org/10.1016/j.eursup.2006.02.006" @default.
- W2022582503 hasPublicationYear "2006" @default.
- W2022582503 type Work @default.
- W2022582503 sameAs 2022582503 @default.
- W2022582503 citedByCount "10" @default.